SELLAS Life Sciences (SLS) Retained Earnings (2019 - 2024)
Historic Retained Earnings for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to -$241.4 million.
- SELLAS Life Sciences' Retained Earnings fell 1544.27% to -$241.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$241.4 million, marking a year-over-year decrease of 1544.27%. This contributed to the annual value of -$217.2 million for FY2023, which is 2075.55% down from last year.
- As of Q3 2024, SELLAS Life Sciences' Retained Earnings stood at -$241.4 million, which was down 1544.27% from -$234.3 million recorded in Q2 2024.
- SELLAS Life Sciences' 5-year Retained Earnings high stood at -$105.3 million for Q1 2020, and its period low was -$241.4 million during Q3 2024.
- Moreover, its 5-year median value for Retained Earnings was -$163.8 million (2022), whereas its average is -$165.9 million.
- As far as peak fluctuations go, SELLAS Life Sciences' Retained Earnings plummeted by 1385.86% in 2021, and later tumbled by 3112.39% in 2022.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Retained Earnings stood at -$117.9 million in 2020, then dropped by 17.56% to -$138.6 million in 2021, then decreased by 29.8% to -$179.9 million in 2022, then decreased by 20.76% to -$217.2 million in 2023, then decreased by 11.12% to -$241.4 million in 2024.
- Its last three reported values are -$241.4 million in Q3 2024, -$234.3 million for Q2 2024, and -$226.8 million during Q1 2024.